Two Sigma Investments, LP Altimmune, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Altimmune, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 454,302 shares of ALT stock, worth $3.94 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

454,302

Previous 576,566 21.21%

Holding current value

$3.94 Million

Previous $3.83 Million 27.26%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.5 - $8.1 $672,452 - $990,338	-122,264 Reduced 21.21%	454,302 $2.79 Million
Q2 2024 Aug 14, 2024	BUY	$5.91 - $10.23 $3.41 Million - $5.9 Million	576,566 New	576,566 $3.83 Million
Q3 2023 Nov 14, 2023	SELL	$2.4 - $3.45 $766,560 - $1.1 Million	-319,400 Reduced 32.37%	667,420 $1.74 Million
Q2 2023 Aug 14, 2023	SELL	$3.45 - $5.97 $197,916 - $342,480	-57,367 Reduced 5.49%	986,820 $3.48 Million
Q1 2023 May 15, 2023	BUY	$4.19 - $16.83 $1.12 Million - $4.51 Million	267,890 Added 34.51%	1,044,187 $4.41 Million
Q4 2022 Feb 14, 2023	SELL	$8.74 - $16.45 $1.76 Million - $3.31 Million	-201,350 Reduced 20.6%	776,297 $12.8 Million
Q3 2022 Nov 14, 2022	BUY	$10.67 - $22.41 $3.86 Million - $8.11 Million	362,029 Added 58.81%	977,647 $12.5 Million
Q2 2022 Aug 15, 2022	BUY	$3.94 - $11.77 $44,120 - $131,800	11,198 Added 1.85%	615,618 $7.2 Million
Q1 2022 May 16, 2022	BUY	$5.9 - $9.45 $165,188 - $264,581	27,998 Added 4.86%	604,420 $3.68 Million
Q4 2021 Feb 14, 2022	BUY	$8.69 - $12.48 $5.01 Million - $7.19 Million	576,422 New	576,422 $5.28 Million
Q2 2021 Aug 16, 2021	SELL	$9.85 - $16.46 $260,030 - $434,527	-26,399 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$12.71 - $24.31 $183,697 - $351,352	-14,453 Reduced 35.38%	26,399 $373,000
Q4 2020 Feb 16, 2021	SELL	$7.84 - $14.22 $4.79 Million - $8.69 Million	-611,316 Reduced 93.74%	40,852 $461,000
Q3 2020 Nov 16, 2020	BUY	$9.93 - $33.26 $6.32 Million - $21.2 Million	636,269 Added 4001.94%	652,168 $8.61 Million
Q2 2020 Aug 14, 2020	BUY	$2.9 - $10.71 $46,107 - $170,278	15,899 New	15,899 $170,000
Q1 2019 May 15, 2019	SELL	$2.54 - $4.54 $31,701 - $56,663	-12,481 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.72 - $7.24 $21,467 - $90,362	12,481 New	12,481 $26,000

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $426M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Altimmune, Inc. Transaction History